Repurposing Research for Chicago 2026: Track 2 – Patient Groups supports Chicago-area researchers testing existing therapies for unsolved diseases in underserved groups, children, rare disease patients, and military groups.
Cures Within Reach funds clinical trials using AI to validate repurposed therapies for unsolved diseases, prioritizing rare conditions and explainable AI workflows.
2026 ReGRoW supports underresourced researchers in low and lower-middle income countries to test repurposed therapies for unsolved diseases, seeking affordable treatments and stronger local research capacity.
Clinical Cancer Research supports investigators conducting patient-centered cancer trials and early-detection studies to improve treatment options, enable earlier intervention, and enhance quality of life.
A Collaborative Pediatric Cancer Research Awards Program supports fellows, investigators, and consortia studying childhood cancers to advance discoveries, safer treatments, and patients’ quality of life.
Emerging Health Innovators supports early-career researchers with research funding and mentorship to develop bold biotechnology and healthcare solutions that address gaps in the U.S. healthcare system.